标题
New biomarkers and targets in pancreatic cancer and their application to treatment
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume 9, Issue 8, Pages 435-444
出版商
Springer Nature
发表日期
2012-06-26
DOI
10.1038/nrgastro.2012.119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
- (2012) Matias E Valsecchi et al. BMC CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
- (2012) Hiroshi Haeno et al. CELL
- Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
- (2012) David A. Tuveson et al. CELL
- The Genetic Basis for Cancer Treatment Decisions
- (2012) Janet E. Dancey et al. CELL
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
- (2012) James A. McCubrey et al. CURRENT PHARMACEUTICAL DESIGN
- Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
- (2012) Meredith A. Collins et al. JOURNAL OF CLINICAL INVESTIGATION
- Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
- (2012) Natalie Cook et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study
- (2012) Andreia de Albuquerque et al. ONCOLOGY
- Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
- (2012) Andrea S. Bauer et al. PLoS One
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- New Approaches to the Treatment of Pancreatic Cancer
- (2011) Maeve A. Lowery et al. BIODRUGS
- Enhancing the translation of cancer biomarkers
- (2011) E. Costello et al. BRITISH JOURNAL OF SURGERY
- Improving outcome for patients with pancreatic cancer through centralization
- (2011) V. E. P. P. Lemmens et al. BRITISH JOURNAL OF SURGERY
- Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
- (2011) D. Olmos et al. CLINICAL CANCER RESEARCH
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- Novel Approaches to Target Pancreatic Cancer
- (2011) M. Porzner et al. CURRENT CANCER DRUG TARGETS
- microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma
- (2011) Adam E Frampton et al. Expert Review of Anticancer Therapy
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
- (2011) Eric A Collisson et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
- (2010) Raphaël Maréchal et al. CANCER
- Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer
- (2010) Gilda da Cunha Santos et al. CANCER
- Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
- (2010) P. J. Grippo et al. Cancer Prevention Research
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
- (2010) S. N. Khleif et al. CLINICAL CANCER RESEARCH
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Targeting Notch signaling in pancreatic cancer
- (2010) Elodie Ristorcelli et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of serum proteins involved in pancreatic cancer cachexia
- (2010) Klaus Felix et al. LIFE SCIENCES
- The patterns and dynamics of genomic instability in metastatic pancreatic cancer
- (2010) Peter J. Campbell et al. NATURE
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
- (2010) Jin-Hyeok Hwang et al. PLoS One
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
- (2009) J P Neoptolemos et al. BRITISH JOURNAL OF CANCER
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
- (2009) R. Marechal et al. CLINICAL CANCER RESEARCH
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma
- (2009) Ruben Plentz et al. GASTROENTEROLOGY
- The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families
- (2009) C. J. Grocock et al. GUT
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- The Hedgehog Pathway and Pancreatic Cancer
- (2009) Manuel Hidalgo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breaching the Cancer Fortress
- (2009) P. Olson et al. SCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- New treatment options for advanced pancreatic cancer
- (2009) Gary Middleton et al. Expert Review of Gastroenterology & Hepatology
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer
- (2008) A. Jimeno et al. CANCER RESEARCH
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer
- (2008) G Feldmann et al. GUT
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
- (2008) G. Feldmann et al. MOLECULAR CANCER THERAPEUTICS
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search